SHAREHOLDER ALERT: CTL BPI CRBP ARA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

CenturyLink, Inc. (NYSE: CTL)
Lead Plaintiff Deadline: May 6, 2019
Class Period: May 10, 2018 and March 4, 2019

Get additional information about CTL: http://www.wongesq.com/pslra-1/centurylink-inc-loss-submission-form?wire=3

Bridgepoint Education Inc. (NYSE: BPI)
Lead Plaintiff Deadline: May 10, 2019
Class Period: March 8, 2016 and March 7, 2019

Get additional information about BPI: http://www.wongesq.com/pslra-1/bridgepoint-education-inc-loss-submission-form?wire=3

Corbus Pharmaceuticals Holdings, Inc. (NASDAQGM: CRBP)
Lead Plaintiff Deadline: May 13, 2019
Class Period: November 14, 2016 and February 28, 2019

Get additional information about CRBP: http://www.wongesq.com/pslra-1/corbus-pharmaceutical-holdings-inc-loss-submission-form?wire=3

American Renal Associates Holdings, Inc. (NYSE: ARA)
Lead Plaintiff Deadline: May 28, 2019
Class Period: August 10, 2016 and March 27, 2019

Get additional information about ARA: http://www.wongesq.com/pslra-1/american-renal-associates-holdings-inc-loss-submission-form?wire=3

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.